. f Figure of merit is Ͻ|⌺ P(␣) e i␣ /⌺ P(␣)|Ͼ, where ␣ is the phase and P(␣) is the phase probability distribution. g R factor ϭ ⌺||F obs |Ϫ|F calc ||/⌺|F obs |.
barrel motif taken by members of the lipocalin family residues Lys-144 and Lys-145. However, in the crystal structure, ␤8 strand is integrated into the core ␤ sheet (Sacchettini and Gordon, 1993; LaLonde et al., 1994; Flower, 1996) . One side of the ␤ sheet core is covered and remains associated with the protein. by a 17-residue ␣ helix, ␣3 (residues 107-123); a welldefined 12-residue loop (residues 57-68); a 2-turn ␣ helix, ␣1 (residues 25-30); and a 3-turn ␣ helix, ␣2 (residues Structure of the Dimer There is one monomer in the asymmetric unit of the 34-42), which are connected by a short turn. Surprisingly, the crystal structure revealed the proteolytic crystal. However, biochemical data obtained from dynamic light scattering and gel filtration experiments indicleavage of the C-terminal ␤8 strand (residues 148-158) from the preceding ␤7 strand that occurs during the cate that BRC is dimeric (Markham et (A) Ribbon diagram of the BRC monomer with the secondary structure elements depicted as coils for ␣ helices, arrows for ␤ strands, and tubes for other structures. Labeled are the amino (N) and the carboxyl (C) termini and the trypsin cleavage site. The protein is composed of strand ␤1 (residues 6-10), strand ␤2 (residues 13-18), helix ␣1 (residues 24-30), helix ␣2 (residues 34-42), strand ␤3 (residues 51-55), strand ␤4 (residues 69-74), strand ␤5 (residues 89-93), strand ␤6 (residues 96-104), helix ␣3 (residues 107-123), strand ␤7 (residues 132-137), and strand ␤8 (residues 149-157). The disordered residues 142-147 are not shown. Loops that have poor electron density (residues 43-47 and 77-80) are shown in white. Helix ␣2 (residues 34-42), which becomes disordered upon TPP binding, is shown in red. This figure was generated with MOLSCRIPT (Kraulis, 1991). potential dimers that are created by the symmetry operinsoluble, whereas the Glu19Gln mutant, in which the metal binding should be weaker, retains solubility but, ators of the tetragonal unit cell. In one of them, both subunits are related by a crystallographic two-fold symunlike the wild-type variant, precipitates upon storage. metry ( Figure 1B) as the wild-type BRC. None of the mutants, however, However, when the flexible-loop residues 76 and 81-83, which neighbor disordered residues 77-80, are exwas able to bind rhodamine to any measurable extent (at least 20-fold reduction as compared to wild type), cluded from the overlay, the rmsd is only 0.61 Å for the monomer and 0.63 Å for the dimer. As found in the strongly supporting the key electrostatic role of residue Glu-134 in drug binding. It remained unclear, however, dimer interface of the apo protein, a divalent metal ion is coordinated identically by residues Glu-19, His-70, how Glu-134 could participate in drug binding, considering that it is completely buried within the hydrophobic and their dyadic mates. As no metal salts were added to the crystallization solution, the metal ion appears to core of the protein.
be carried from the cell through protein purification and crystallization, and its identity is unknown. The observed unfolding of helix ␣2 is critical for drug changes in the BRC protein, which make the binding pocket accessible to the drug. These changes involve binding. In the absence of drugs, helix ␣2 lies across the drug-binding pocket and completely blocks access helices ␣1 and ␣2 and the turn connecting them (Figure  3, bottom) . In contrast to the apo structure, helix ␣1 is to the binding site (Figure 3, top; Figure 5 , left). Furthermore, helix ␣2 stabilizes the apo conformation by inrotated ‫01ف‬Њ around its amino terminus, and its carboxyl terminus (residue Asn-30) is unwound. The tight turn serting residues Tyr-33 and Leu-36 into the core of the protein with the former residue hydrogen bonding to connecting helices ␣1 and ␣2, residues Ala-31-Ser-32-Tyr-33, unfolds and extends into the solvent such that Glu-134 (Figure 2 ) and the latter making van der Waals contacts to core residues Val-28 and Ile-23. To bind the C␣ atom of Tyr-33 is translated 11.5 Å from its apo position and its side chain is completely removed from TPP, helix ␣2 must relocate, which, in turn, requires the helix to unfold because of the stereochemical conthe protein core. The repositioning of residue Tyr-33 is especially important because in the apo structure, Tyrstraints of the BRC structure (i.e., a folded nine-residue ␣ helix would be too short to connect residue Ser-34 to 33 contributes one of the internal hydrogen bonds to the buried carboxylate of Glu-134 (Figure 2) , a bond residue Ser-42 [ Figure 3 , bottom]). These drug-dependent conformational changes lead to the exposure of the that is broken when drug binding takes place. A water TPP-BRC complex reveal the helix-to-coil transition of helix ␣2 that is required for high-affinity drug binding.
BRC-TPP Complex Structure Determination

Structure Determination of Apo BRC
Moreover, the structures identify residue Glu-134, which 
